New standards for evaluating Alzheimer's infection

Experts in Alzheimer’s disease work the method of diagnosing patients with this cerebral deviation, which is the most common dementia by placing an evaluation scale of 7 points based on the cognitive and biological changes of the patient. Reuters said that the proposed guidelines announced by experts on Sunday, in a report issued at the Alzheimer’s International Association in the Netherlands, accepted the digital gradient system to assess the development of the disease similar to the user in the diagnosis of cancer, and it can also cancel the use of terms such as moderate, medium and seriously. The agency noted that the motivation behind this modernization process, which will replace the instructions released in 2018, is to increase the availability of tests that reveal the most important proteins associated with the disease, such as ‘amyloid beta’ in the blood, and new treatments that require procedures before using. “This new system is designed to be more accurate, and it better expresses the level of the disease,” says Dr. Calphord Jack of Mayo Clinic in the United States. This change comes in a time when doctors are preparing to treat patients using the LeQembi medicine produced by Japanese pharmaceutical company Eisai in collaboration with the US company Biogen, which has approved the FDA Food and Drug Administration this month, and Eli Lilly Experimental Drugabab, which now undergoes a revision of the US food and drug administration. “We are entering an era of the most specialized medicine, because we have begun to understand that there are some important indicators that rise at different degrees in people at different stages,” said Dr. Maria Carillo, the chief scientist official of Alzheimer’s Association, said. According to the new diagnostic approach, patients will get some 1 to 7 based on the presence of abnormally important indicators of the disease, and the extent of cognitive changes, as the system includes 4 biological stages arranged: A, B, C, D, for example, stage 1 A is when the person is completely symptoms, but he has an abnormal biomus showers. ‘With the disease.’ In the second phase, the individual may have abnormally important indicators and many minor changes in the level of perception or behavior, while phase 3 is equal to the stage currently known as the moderate cognitive weakness, while the 4, 5 and 6 light dementia equals Down syndrome, with 75% of them later in their lives. Symptom treatment. According to a spokesperson for the Alzheimer’s Association, the draft lines will be available to review and deliver experts and will later be amended to reflect this input. Also read: